| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 07/03/2008 | WO2008024188A8 Dual variable domain immunoglobulin and uses thereof |
| 07/03/2008 | US20080163399 Axmi-008, a delta-endotoxin gene and methods for its use |
| 07/03/2008 | US20080161543 Modified Clostridial Toxins With Altered Targeting Capabilities For Clostridial Toxin Target Cells |
| 07/03/2008 | US20080161243 Chimeric B-type natriuretic peptide (BNP) polypeptide for use in treatment and prevention of cardiovascular disorders |
| 07/03/2008 | US20080161240 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 07/03/2008 | US20080161227 Peptide IPP is generated in high yields from preferably a small molecular weight protein having a high amount of -I-P-P- compared to -V-P-P- in its amino acid sequence; preferably the GMP fraction of kappa-casein is used; process comprises a single enzyme incubation step |
| 07/03/2008 | US20080161226 Activatable Clostridial Toxins |
| 07/03/2008 | US20080160616 Using sited directed insertion of vectors as tool in generating transgenic cell lines |
| 07/03/2008 | US20080160609 Dihydrofolate reductase; site directed mutagenesis; point mutations; auxotroph host cells |
| 07/03/2008 | US20080160577 Optimization of Heterologous Polypeptide Expression |
| 07/03/2008 | US20080160576 Anti-alphabeta3 humanized monoclonal antibodies |
| 07/03/2008 | US20080160574 Chimeric coiled coil molecules |
| 07/03/2008 | US20080160573 Mutant alpha-amylases |
| 07/03/2008 | US20080160572 Using gramnegative bacteria as bioreactor for expression of yfcK gene (peptidase); protein processing tool in heterologous gene expression |
| 07/03/2008 | US20080160571 Antibodies that bind TNF-alpha converting enzyme |
| 07/03/2008 | US20080160570 Using escherichia as bioreactor for production of ubiquitin-somatotropin fusion protein for use in treatment of growth abnormalities |
| 07/03/2008 | US20080160569 Having up to 5,000 times water absorption capacity, improved firmness, and long-term stability after full swelling in water or an aqueous medium; for use in cosmetics, agricultural and horticultural, civil construction, medical and hygiene, or bioengineering applications |
| 07/03/2008 | US20080160513 Characterization of Mcra Subunits and Uses Thereof |
| 07/03/2008 | US20080160507 Using cell-free protein synthesis mixture for use in translation and assembly of retroviral capsid and capsid intermediate particles |
| 07/03/2008 | US20080160054 vectors or transgenic organisms; biosynthesis; derived from Physcomitrella |
| 07/03/2008 | US20080160035 Cytokine specific immunoglobulin for use in diagnosis, prevention and treatment ,of cell proliferative, inflammatory, allergic, respiratory, autoimmune and arthritic disorders |
| 07/03/2008 | US20080160033 Novel Screening Method |
| 07/03/2008 | US20080160021 Antagonist antibody or fragment that binds to a specific polypeptide, used for the treatment of a degenerative cartilaginous disorder, including osteo-, rheumatoid and psoriatic arthritis |
| 07/03/2008 | US20080160018 Using mik- beta 1 monoclonal antibody as therapeutic tool in treatment and prevention of graft vs. host, autoimmune and diabetic disorders |
| 07/03/2008 | US20080160016 Compositions and methods of tolerizing a primate to an antigen |
| 07/03/2008 | US20080160015 Monoclonal antibody for use in treatment of hemophila |
| 07/03/2008 | US20080160011 Alpha-synuclein kinase |
| 07/03/2008 | US20080160008 Methods and compositions for reducing amyloid beta levels |
| 07/03/2008 | US20080160002 Tumor necrosis factor cleaving agent for use in diagnosis, prevention and treatment of inflammatory disorders |
| 07/03/2008 | US20080159993 Immunotherapeutic methods using epitopes of WT-1 and GATA-1 |
| 07/03/2008 | US20080159986 Modulators of the functions of receptors of the tnf/ngf receptor family and other proteins |
| 07/03/2008 | CA2673639A1 Human antibodies that bind human il-12 and methods for producing |
| 07/02/2008 | EP1939297A1 Alzheimer's disease secretase |
| 07/02/2008 | EP1939293A2 Interferon-Like Protein ZCYTO21 |
| 07/02/2008 | EP1939286A1 Novel peptides |
| 07/02/2008 | EP1939212A1 Organic compounds |
| 07/02/2008 | EP1937827A1 Antibodies and their use in the treatment, prevention and diagnosis of a disease associated with sod1 abnormalities |
| 07/02/2008 | EP1937826A1 Enzymatic conversion of oligopeptide amides to oligopeptide alkylesters |
| 07/02/2008 | EP1937824A1 COMPOSITIONS OF tRNA AND USES THEREOF |
| 07/02/2008 | EP1937718A2 Chimeric human sweet-umami and umami-sweet taste receptors |
| 07/02/2008 | EP1937313A2 Host cell lines for production of antibody constant region with enhanced effector function |
| 07/02/2008 | EP1748073B1 Recombinant d-amino acid oxidase |
| 07/02/2008 | EP1497429B1 Improved bacillus host cell |
| 07/02/2008 | EP1401851B1 Two-stage protective groups for the synthesis of biopolymers |
| 07/02/2008 | EP1385950B1 Computer-directed assembly of a polynucleotide encoding a target polypeptide |
| 07/02/2008 | EP1171468B1 Method for the Stabilization of Chimeric Immunoglobulins or Immunoglobulin Fragments, and Stabilized Anti-EGP-2-scFv Fragment |
| 07/02/2008 | EP1169347B1 Compounds and methods for therapy and diagnosis of lung cancer |
| 07/02/2008 | EP1141003B9 Methods of activation of SGK by phosphorylation. |
| 07/02/2008 | EP0973940B1 An in vitro method for the construction of a dna library |
| 07/02/2008 | EP0896055B1 Apoptosis inducing protein and gene encoding the same |
| 07/02/2008 | CN101213308A Collagen protein artificial product, collagen solution manufacturing method and collagen separation method of animal tissue |
| 07/02/2008 | CN101213297A Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics |
| 07/02/2008 | CN101213295A Mutant PCNA |
| 07/02/2008 | CN101213294A Scalable fermentation process |
| 07/02/2008 | CN101210261A Method for preparing sipunculid polypeptide and application thereof |
| 07/02/2008 | CN101210051A Anti-VEGF antibodies |
| 07/02/2008 | CN101210050A Anti-vegf antibodies |
| 07/02/2008 | CN101210043A Rice bran immune peptide and preparing method thereof |
| 07/02/2008 | CN100398661C Casein hydrolyzate, process for producing the same and use thereof |
| 07/02/2008 | CN100398660C Method for producing compound bioactive peptide utilizing casein enzyme process |
| 07/02/2008 | CN100398653C Novel streptococcus antigens |
| 07/02/2008 | CN100398650C Recombinant human II type collagen functional polypeptide C II 250-270 and its preparation method and application |
| 07/02/2008 | CN100398562C Monoclonal antibody ZUF10 of human bone marrow mesenchymal stem cells and application |
| 07/02/2008 | CN100398557C Polypeptide for inhibition of angiogenesis and method for preparing same and use thereof |
| 07/01/2008 | US7393945 Estrogen receptor genes and utilization thereof |
| 07/01/2008 | US7393944 Lymphocytes; transcription factors; interferons |
| 07/01/2008 | US7393943 for the treatment of leukemia, tumors, chronic infections, auto-immune disease, fibrotic disorders, wound healing and psoriasis |
| 07/01/2008 | US7393942 Nucleic acids encoding mutant forms of Fas ligand |
| 07/01/2008 | US7393941 screening assay to identify agents having antiviral activity against a DNA virus by assessing the effect of a candidate agent upon alternative splicing of MxA |
| 07/01/2008 | US7393936 Method for the recombinant production and purification of protein kinases |
| 07/01/2008 | US7393933 Hepatitis B monoclonal antibodies |
| 07/01/2008 | US7393932 Endothelial cell expression patterns |
| 07/01/2008 | US7393931 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins |
| 07/01/2008 | US7393928 Recombinant gelatins |
| 07/01/2008 | US7393927 Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same, and methods of use thereof |
| 07/01/2008 | US7393918 Protein binding miniature proteins and uses thereof |
| 07/01/2008 | US7393684 Immunoconjugates of anti-IL-20 antibodies and hybridoma cell lines expressing anti-IL-20 antibodies |
| 07/01/2008 | US7393683 Mammalian host cell modified by RNAi to inhibit α 1,6-fucosyltransferase |
| 07/01/2008 | US7393673 Mixture containing glucanase for use in degradation of plant biomass and pollution control |
| 07/01/2008 | US7393671 Mutant carotenoid ketolases |
| 07/01/2008 | US7393664 Preparing transgenic fungal bioreator for propagation and expression of heterologous proteins |
| 07/01/2008 | US7393663 For diagnostics/forensics/gene therapy/chromosome mapping; expression vector design/secretion |
| 07/01/2008 | US7393662 Human EPO mimetic hinge core mimetibodies, compositions, methods and uses |
| 07/01/2008 | US7393659 Digesting a sample of a nutritional product and a reagent blank with enzyme; terminating digestion; determining total concentration of each of a plurality of amino acids for the sample and blank; determining total tryptophan concentration |
| 07/01/2008 | US7393655 Nucleotide sequences coding cyclic peptide receptor for use in identifying modulators for treatment of pituitary hormone, epinephrine release, gastrointestinal, cardiovascular, electrolyte balance, hypertensive, diabetic and respiratory system disorder |
| 07/01/2008 | US7393653 Using mitochondrial proteins (BIT-1) and amino enhancer of split (AES) sequences as tools in identifying modulator for treatment of cell proliferative disorders |
| 07/01/2008 | US7393648 Hybrid antibodies |
| 07/01/2008 | US7393647 Kit comprising affinity agent immobilized on microtiter plate, forms complex with labeled antibody; surface array proteins; diagnosing anthrax |
| 07/01/2008 | US7393549 Defructosylation method |
| 07/01/2008 | US7393536 Nucleotide sequences coding streptococcus capsular polysaccharide antigens for use in diagnosis and prevention of infections in mammals; veterinary medicine |
| 07/01/2008 | US7393531 Cytotoxicity mediation of cells evidencing surface expression of MCSP |
| 07/01/2008 | US7393529 Antiallergens |
| 06/26/2008 | WO2008076933A2 Long acting proteins and peptides and methods of making and using the same |
| 06/26/2008 | WO2008075279A2 Biodegradable polymeric derivatives |
| 06/26/2008 | WO2008074724A1 Organic compounds |
| 06/26/2008 | WO2008017646A3 Expression of genes from gram negative bacteria in fungi |
| 06/26/2008 | WO2008005828A3 PHARMACEUTICALLY ACCEPTABLE COMPOSITIONS COMPRISING ANTIBODY MOLECULES SPECIFIC TO LAMININ-5 α3 CHAIN DOMAINS G1G2 AND USE THEREOF |
| 06/26/2008 | US20080153751 Albumin Fusion Proteins |
| 06/26/2008 | US20080153750 Fermenting an appropriate microorganism using glucose as a carbon source and separating by chromatography, has a purity of at least 98%; specific binding or targeting to transferrin; use in the treatment of CNS neoplasm; antitumor agents |
| 06/26/2008 | US20080153747 taipan natriuretic peptide is used for treating congestive heart failure, stimulating vasodilation, natriuresis, diuresis, renin-suppression, bactericidal activity, weight-loss or bone growth; antigen-binding molecule |